Frank Hullekes, Audrey Uffing, Rucháma Verhoeff, Harald Seeger, Seraina von Moos, Juliana Mansur, Gianna Mastroianni-Kirsztajn, Helio Tedesco Silva, Anna Buxeda, María José Pérez-Sáez, Carlos Arias-Cabrales, A Bernard Collins, Christie Swett, Leela Morená, Marina Loucaidou, Andreas Kousios, Paolo Malvezzi, Mathilde Bugnazet, Luis Sanchez Russo, Saif A Muhsin, Nikhil Agrawal, Pitchaphon Nissaisorakarn, Het Patel, Ayman Al Jurdi, Enver Akalin, Elias David Neto, Fabiana Agena, Carlucci Ventura, Roberto C Manfro, Andrea Carla Bauer, Marilda Mazzali, Marcos Vinicius de Sousa, Gaetano La Manna, Claudia Bini, Giorgia Comai, Roman Reindl-Schwaighofer, Stefan Berger, Paolo Cravedi, Leonardo V Riella
Membranous nephropathy (MN) is a leading cause of kidney failure worldwide, and frequently recurs after transplant. Available data originated from small retrospective cohort studies or registry analyses. Therefore, uncertainties remain on risk factors for MN recurrence and response to therapy. Within the Post-Transplant Glomerular Disease (TANGO) Consortium, we conducted a retrospective multicenter cohort study examining the MN recurrence rate, risk factors, and response to treatment. This study screened 22,921 patients across three continents and included 194 patients who underwent a kidney transplant due to biopsy-proven MN...
February 8, 2024: American Journal of Transplantation